Ondansetron HCL 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FE6K1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,127
Award facts
- Contract value 100% obligated
- $12,126.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Ondansetron HCl 8 mg tablets (30-count) with a ceiling value of $12,126.92. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract has an ultimate completion date of September 15, 2025, and performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This ondansetron order represents a routine pharmaceutical delivery consistent with AmerisourceBergen's extensive portfolio of federal medical product deliveries across multiple therapeutic domains. The company has demonstrated capability to fulfill federal procurement requirements through open competition, with all reviewed contract awards being non-set-aside and competitively awarded.
Quick answers
Who was awarded contract SPE2DB25FE6K1?
SPE2DB25FE6K1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FE6K1 worth?
The government has obligated $12,127 on SPE2DB25FE6K1.
Is contract SPE2DB25FE6K1 an order under another contract?
Yes. SPE2DB25FE6K1 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE6K1 competed?
The extent of competition for SPE2DB25FE6K1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award